Matches in Wikidata for { <http://www.wikidata.org/entity/Q91593373> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91593373 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q91593373 description "im März 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91593373 description "scientific article published on 31 March 2020" @default.
- Q91593373 description "wetenschappelijk artikel" @default.
- Q91593373 description "наукова стаття, опублікована 31 березня 2020" @default.
- Q91593373 name "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 name "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 type Item @default.
- Q91593373 label "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 label "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 prefLabel "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 prefLabel "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 P1433 Q91593373-34EBD343-715D-4F46-9D7B-A2241C232F29 @default.
- Q91593373 P1476 Q91593373-48811F9E-042E-423E-AC6F-C94CFD23F0A0 @default.
- Q91593373 P2093 Q91593373-282C9464-854B-4046-AF64-3632F2B70AE9 @default.
- Q91593373 P2093 Q91593373-63DF9057-CBCE-4D2D-BB3B-17BC33ED4E0E @default.
- Q91593373 P2093 Q91593373-A4870108-DCD4-4814-B89E-C5BE6FFE6E6A @default.
- Q91593373 P2093 Q91593373-C590C2E4-7ADE-4FCF-8919-CCE08D14EE8B @default.
- Q91593373 P2093 Q91593373-DF18493C-A53E-4675-AB6D-51A70A54967E @default.
- Q91593373 P31 Q91593373-AD0F31F0-80A6-49FE-8782-8AD79F140B2B @default.
- Q91593373 P356 Q91593373-DEC72B29-2484-4366-9512-394F1D7188E5 @default.
- Q91593373 P577 Q91593373-A3BA6009-C2CF-47A7-82E3-5B5F490153F5 @default.
- Q91593373 P698 Q91593373-049C54DB-937A-47F3-AA53-6EA713D3BE5D @default.
- Q91593373 P921 Q91593373-3D83D9DE-5FF2-4963-8F51-54CEBFE391C4 @default.
- Q91593373 P921 Q91593373-FE2E7655-C1FB-4A0B-AB70-4C72D02DF68D @default.
- Q91593373 P356 RHU.0000000000001361 @default.
- Q91593373 P698 32251060 @default.
- Q91593373 P1433 Q15766312 @default.
- Q91593373 P1476 "Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study" @default.
- Q91593373 P2093 "Alejandra López" @default.
- Q91593373 P2093 "Allan Ramos-Esquivel" @default.
- Q91593373 P2093 "Eduardo Mysler" @default.
- Q91593373 P2093 "Mario H Cardiel" @default.
- Q91593373 P2093 "Ricardo M Xavier" @default.
- Q91593373 P31 Q13442814 @default.
- Q91593373 P356 "10.1097/RHU.0000000000001361" @default.
- Q91593373 P577 "2020-03-31T00:00:00Z" @default.
- Q91593373 P698 "32251060" @default.
- Q91593373 P921 Q187255 @default.
- Q91593373 P921 Q425154 @default.